1 in 4 people in the U.S. struggles with allergies, asthma or both. BRI has made significant breakthroughs in understanding how these conditions occur.
The Immune Tolerance Network (ITN), led by Benaroya Research Institute (BRI), has made major breakthroughs in fighting peanut allergies.
The history of how BRI's current home at 1201 Ninth Ave. came to be.
Scientists at BRI recently received a $2.2 million grant from the NIH to find a unique biomarker that initiates and drives allergies.
Adam Lacy-Hulbert, PhD, bring new expertise in Inflamatory Bowel Disease (IBD) and the basic functioning of the immune system.
© 2020 Benaroya Research Institute at Virginia Mason. 1201 Ninth Avenue, Seattle, WA 98101-2795
Your donation to the COVID-19 Rapid Response Fund will directly support urgent research into the immune system response to the virus. With your help, we can get to answers faster to bring an end to this public health crisis.
No thanks, close this window